Morpheus8 for Excessive Armpit Sweating: Full Hyperhidrosis Guide

In this guide13 sections

What is axillary hyperhidrosis?
How Morpheus8 treats hyperhidrosis
What to expect during treatment
How many sessions do I need?
What results to expect
How does Morpheus8 compare to other hyperhidrosis treatments?
The hyperhidrosis treatment ladder
What does Morpheus8 hyperhidrosis treatment cost?
Recovery from underarm Morpheus8
Who’s a good candidate?
What we don’t recommend
Frequently asked questions
References

Excessive underarm sweating — clinically termed axillary hyperhidrosis — affects a substantial minority of the population and can be a source of significant daily discomfort and social anxiety. Standard management options range from prescription antiperspirants to anti-sweat injections to surgical sweat gland removal. Morpheus8 offers a middle-ground option that’s less invasive than surgery, reducing sweat through fractional radiofrequency microneedling applied directly to the underarm sweat glands.

This guide covers how Morpheus8 treats hyperhidrosis, who’s a good candidate, what results to expect, how it compares to alternatives, and where it fits in the broader hyperhidrosis treatment ladder at Centre for Surgery’s CQC-regulated Baker Street private hospital.

What is axillary hyperhidrosis?

Axillary hyperhidrosis is excessive sweating in the underarm area beyond what’s needed for normal temperature regulation. The condition affects approximately 2–3% of the population and typically begins in adolescence or early adulthood. It’s a recognised medical condition, not just a nuisance — patients often:

Change clothes multiple times a day
Avoid certain fabrics or colours (light blues, greys, anything that shows sweat patches visibly)
Limit social and professional situations (public speaking, intimate occasions, dating)
Use multiple antiperspirants daily without adequate control
Experience significant psychological impact — anxiety, embarrassment, reduced self-confidence
Develop skin problems (chronic moisture leading to fungal or bacterial issues)

The condition runs in families — about two-thirds of patients have a family history. It can be primary (no underlying cause) or secondary (related to thyroid disorders, certain medications, or other medical conditions). Generalised hyperhidrosis affecting the whole body needs broader medical assessment to rule out systemic causes; localised axillary hyperhidrosis is typically primary.

How Morpheus8 treats hyperhidrosis

Sweat glands sit in the dermis and upper subcutaneous layer of the skin — relatively superficial in anatomical terms but beyond the reach of topical treatments. Morpheus8’s fractional radiofrequency microneedling delivers controlled thermal energy directly at the depth where these glands sit (typically 2–4mm beneath the skin surface).

The mechanism is straightforward thermal ablation:

Microneedles penetrate the skin to the depth of the sweat glands
RF energy delivers heat at the needle tips, raising local tissue temperature beyond what sweat glands can survive
Targeted glands are thermally damaged, reducing their functional capacity
The body clears the damaged glands over the following weeks
Sweat production drops proportionally to the number of glands affected

Unlike anti-sweat injections (which temporarily block the chemical signal that activates sweat glands), Morpheus8 produces structural reduction in gland function: biopsies taken after treatment show fewer sweat glands in the treated skin^[1]. How long that lasts varies between patients, and published follow-up so far extends to one year^[2].

The insulated needle technology delivers RF heat at depth without thermal damage to the surface skin, which keeps the recovery short and side effects minimal. The treatment is safe across all Fitzpatrick skin types because the epidermis isn’t directly heated.

What to expect during treatment

Preparation

You arrive at our Baker Street clinic with clean, shaved underarms (shaving 24+ hours before, not immediately before). A strong topical anaesthetic cream is applied to both underarms and left in place for 45–60 minutes. For deeper protocols or pain-sensitive patients, local anaesthetic injection can be added.

The treatment

Once numbing is complete, the clinician applies the Morpheus8 handpiece across the underarm area in overlapping passes, treating the entire sweat-bearing zone. Treatment depth is typically 2–4mm — deep enough to reach the sweat glands but not into deeper tissue. The active treatment takes 20–30 minutes for both underarms combined.

The sensation is similar to facial Morpheus8 — warm prickling with the topical numbing in place. The underarm area can be more sensitive than facial skin, which is why we offer enhanced anaesthesia when needed.

Immediately after

Mild redness and warmth in the treated areas, with minor pinpoint bleeding spots. The clinician applies a soothing balm and provides aftercare instructions. You leave the clinic immediately and can drive home.

How many sessions do I need?

Most patients benefit from 2–3 sessions, 4–6 weeks apart. The exact number depends on the severity of your hyperhidrosis:

Mild-to-moderate hyperhidrosis — 2 sessions typically sufficient
Moderate-to-severe hyperhidrosis — 3 sessions for optimal control
Severe cases or patients with high BMI — 3–4 sessions may be needed; some patients benefit from additional top-up sessions over time, and relapse is more likely at a higher BMI^[2]

Each session reduces the active sweat gland population further. Like facial Morpheus8, the response is cumulative — each session builds on the previous one.

What results to expect

The pattern of sweat reduction develops over weeks following treatment:

Week 1 — initial inflammation in treated area; sweat reduction not yet apparent
Weeks 2–4 — early sweat reduction beginning as treated glands are cleared by the body
Weeks 6–8 — meaningful sweat reduction visible after the first session; planning second session
After 2 sessions — substantial reduction in sweat output for most patients
After 3 sessions — peak result; in a two-session pilot study, the sweating area on starch-iodine testing fell by about a third^[3], and in a sham-controlled trial 79% of patients improved by one or two points on the four-point severity scale^[1]
Long-term — in the longest study, about four in ten patients had no relapse at one year and just under half had some return of sweating; the authors advise a repeat session after a year^[2]

Most patients describe the result as “still sweating like a normal person rather than not at all” — which is the appropriate clinical goal. Complete elimination of sweating in the underarms isn’t desirable (sweating helps with temperature regulation) and isn’t what Morpheus8 aims to achieve. The treatment normalises rather than eliminates.

How does Morpheus8 compare to other hyperhidrosis treatments?

Vs anti-sweat injections (botulinum toxin)

Anti-sweat injections deliver botulinum toxin to the sweat glands, temporarily blocking the chemical signal that triggers sweat production. The treatment is effective but temporary — typically lasting around 4–7 months before needing repeat injection^[4]. Many patients find the recurring cost and need for re-treatment a significant ongoing commitment.

In head-to-head trials, injections reduced sweating more than fractional microneedle RF at 12 weeks (Rummaneethorn and Chalermchai, 2020 ↗)^[5] and again at 12 months, where the RF treatment was also more painful (Eid et al., 2024 ↗)^[6]. A 2026 systematic review reached the same conclusion^[7]. Morpheus8 can suit patients who want to move away from repeat injections, but it should not be expected to outperform them.

Vs suction curettage

Suction curettage is a minor surgical procedure. Through small incisions in the underarm, a cannula scrapes the sweat glands away from the underside of the skin and removes them by suction. It reduces sweating more than Morpheus8, but it is not permanent for everyone: in a prospective study, sweat output was 85% lower at one month and 61% lower at two years, with some return of function as the nerves grew back (Feldmeyer et al., 2015 ↗)^[8]. In a comparative study, around half of patients reported mild recurrent symptoms at about two years, although local surgery still outperformed sympathectomy^[9].

The trade-off: suction curettage is a surgical procedure under local anaesthetic with oral sedation (TIVA is available for a supplement if you prefer to be asleep), with a longer recovery of around 2–3 weeks, mild swelling and small surgical scars. Morpheus8 is less invasive but somewhat less definitive.

Vs prescription antiperspirants

Prescription-strength antiperspirants (aluminium chloride hexahydrate) are first-line treatment for mild hyperhidrosis. They work for many patients but are inadequate for moderate-to-severe cases. Morpheus8 is appropriate when prescription antiperspirants have failed or are inadequate.

Vs oral medications

Anticholinergic medications (glycopyrrolate, oxybutynin) reduce sweating systemically but have side effects (dry mouth, blurred vision, constipation, urinary retention). Useful for generalised hyperhidrosis but generally not first-choice for localised axillary sweating.

Vs surgery (endoscopic thoracic sympathectomy)

Surgical sympathectomy permanently divides the nerves controlling sweating to the underarms. Highly effective but invasive: it requires TIVA, and the main complication is compensatory sweating elsewhere on the body. A 2025 meta-analysis of 3,117 patients ↗ found compensatory sweating in about 62% of patients after sympathectomy, and severe compensatory sweating in about 23%^[10]. For underarm-only sweating, a comparative study found local surgery worked better than sympathectomy, with far less compensatory sweating (25% vs 84%)^[9]. Sympathectomy is generally reserved for severe cases that haven’t responded to other treatments. Morpheus8 sits at a much earlier point in the treatment ladder.

The hyperhidrosis treatment ladder

At Centre for Surgery, we offer three main options for axillary hyperhidrosis, suited to different severity levels and patient preferences:

Option	Type	Duration	Best for
Anti-sweat injections	Non-surgical, temporary	4–6 months	Mild–moderate, those wanting to try treatment first
Morpheus8	Minimally invasive, course of sessions	Studied to 1 year; repeat often advised^[2]	Moderate cases, preference for longer-lasting result without surgery
Suction curettage	Minor surgery, local anaesthetic	Long-lasting; 61% less sweat at 2 years in one study^[8]	Severe cases wanting a longer-lasting surgical option

The right choice depends on severity, lifestyle factors, financial commitment preference, and tolerance for procedure invasiveness. Many patients start with anti-sweat injections to confirm whether reducing sweating produces the lifestyle improvement they’re hoping for, then consider Morpheus8 or suction curettage if they want to move away from repeat injections.

What does Morpheus8 hyperhidrosis treatment cost?

Underarm Morpheus8 treatment is priced as a single-area protocol. A typical course of 2–3 sessions is bundled at consultation. Finance (subject to status) through Chrysalis Finance is available to spread the cost.

For comparison:

Anti-sweat injections — repeat costs every 4–7 months; total ongoing expense over years is substantial
Morpheus8 — higher upfront cost for a course of sessions; a repeat session after a year is often advised^[2]
Suction curettage — usually a one-off procedure (priced higher than Morpheus8) with longer-lasting results, though some sweating can return over time^[8]

For full pricing context, see our Morpheus8 cost guide.

Recovery from underarm Morpheus8

Recovery from underarm Morpheus8 is generally similar to facial Morpheus8 with some specifics:

Day of treatment — mild redness, warmth, pinpoint bleeding spots; mild tenderness when raising arms
Days 1–3 — pinkness fading; mild tenderness continuing; avoid antiperspirant during this window
Days 4–7 — surface healing largely complete; can resume normal underarm care
Week 2+ — return to normal activity including exercise

Specific aftercare points:

Avoid shaving the underarms for 7 days post-treatment
Skip antiperspirants for 5 days (use plain moisturiser if needed)
Wear loose, breathable clothing in the first week
Avoid heat exposure (saunas, hot baths) for 5 days
Limit intense exercise for 3–5 days to reduce friction and heat

Who’s a good candidate?

You’re likely to benefit from Morpheus8 for hyperhidrosis if:

You have moderate-to-severe underarm sweating affecting daily life
Prescription antiperspirants haven’t given adequate control
You want longer-lasting results than injection-based treatment
You prefer minimally invasive over surgical options
You’re prepared for 2–3 treatment sessions
You’re in general good health, not pregnant or breastfeeding
You don’t have active skin infection in the treatment area

You may need other options if:

Your hyperhidrosis is generalised rather than localised (broader medical assessment needed)
You have very severe symptoms with significant impact (suction curettage or other surgery may be more appropriate)
You have an underlying medical condition causing sweating (thyroid, infection) — treat that first
You’re not prepared for any visible recovery time

What we don’t recommend

Single sessions as a definitive solution — meaningful results need 2–3 sessions minimum
Morpheus8 for generalised hyperhidrosis — only targeted axillary treatment. Generalised sweating needs systemic treatment.
Skipping antiperspirant trial first — for mild hyperhidrosis, prescription antiperspirants are first-line and substantially cheaper
Using antiperspirant in the first 5 days post-treatment — irritates healing skin
Shaving immediately post-treatment — wait 7 days for surface healing to complete
Treatment without identifying underlying causes — some hyperhidrosis is secondary to medical conditions. Rule out thyroid issues, infections, or medication side effects first.

Frequently asked questions

How long do Morpheus8 hyperhidrosis results last?

The longest published follow-up is one year. In that study (Abtahi-Naeini et al., 2016 ↗), about 42% of patients had no relapse at 12 months and about 46% had some return of sweating, with relapse more likely in patients with a higher BMI. The authors recommend repeating treatment after a year^[2]. In a randomised trial, injections held their effect better than fractional microneedle RF at 12 months^[6]. Results are not permanent, and some patients will need further sessions.

Will I sweat from other body areas more if my underarms are treated?

Mild compensatory sweating can occur in some patients but is much less common with Morpheus8 than with surgical sympathectomy. The body has many sweat glands across the body and reducing one area doesn’t dramatically increase others.

Is the treatment painful?

Comfortable with topical anaesthesia and optional local injection. Underarm skin can be slightly more sensitive than face, which is why enhanced numbing is often offered.

Does Morpheus8 stop sweating completely?

No — the goal is normalising sweat to typical levels rather than eliminating it entirely. Most patients see a meaningful reduction rather than complete dryness. In a sham-controlled trial, 80% of patients reported more than 50% satisfaction with the result^[1].

Can men have Morpheus8 for sweating?

Yes — and many men find this treatment particularly valuable given that hyperhidrosis can affect professional and personal situations significantly.

What about sweating on other body areas (palms, feet, scalp)?

Palmar and plantar hyperhidrosis (palms, feet) is typically treated with iontophoresis, injections or surgery rather than Morpheus8. Scalp hyperhidrosis is harder to address and may need oral medication. We discuss appropriate options at consultation.

Can I have Morpheus8 if I’m on hormone therapy?

Yes, generally. Hormone-related sweating may benefit from the treatment but the underlying hormonal cause should also be addressed where appropriate.

Is the treatment FDA-approved for hyperhidrosis?

Morpheus8 is FDA-cleared for dermatological procedures involving electrocoagulation and haemostasis. It is not specifically cleared for hyperhidrosis, so treating underarm sweating is an off-label use, supported by published studies of fractional microneedle radiofrequency^[1]^[2]^[3].

Why choose Centre for Surgery

We offer the full hyperhidrosis treatment ladder under one clinical team — anti-sweat injections, Morpheus8 underarm treatment, and suction curettage — meaning your consultation establishes which approach suits your specific situation rather than recommending whatever single treatment a single-modality clinic offers. Morpheus8 is delivered on genuine InMode equipment by GMC-registered medical practitioners at our CQC-regulated Baker Street private hospital. Course pricing is all-inclusive with follow-up reviews included.

For more, see our Morpheus8 service page, anti-sweat injections, and suction curettage for hyperhidrosis service.

References

Fatemi Naeini F, Abtahi-Naeini B, Pourazizi M, Nilforoushzadeh MA, Mirmohammadkhani M. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: a sham control study. Australas J Dermatol. 2015;56(4):279–284. doi:10.1111/ajd.12260 ↗
Abtahi-Naeini B, Naeini FF, Saffaei A, et al. Treatment of primary axillary hyperhidrosis by fractional microneedle radiofrequency: is it still effective after long-term follow-up? Indian J Dermatol. 2016;61(2):234. doi:10.4103/0019-5154.177789 ↗
Jung JM, Na HM, Kim JH, et al. The efficacy and safety of a fractional microneedle radiofrequency device for the treatment of axillary hyperhidrosis: clinical prospective pilot study. Lasers Med Sci. 2022;37(3):1559–1566. doi:10.1007/s10103-021-03404-z ↗
Pongsarikan P, Koonngam P. Botulinum toxin A for primary axillary hyperhidrosis: a narrative review. J Med Life. 2026;19(6):420–425. doi:10.25122/jml-2026-0005 ↗
Rummaneethorn P, Chalermchai T. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis. Lasers Med Sci. 2020;35(5):1179–1184. doi:10.1007/s10103-020-02958-8 ↗
Eid RO, Shaarawi E, Hegazy RA, Hafez V. Long-term efficacy of fractional microneedle radiofrequency versus botulinum toxin-A in primary axillary hyperhidrosis: a randomized controlled trial. Lasers Med Sci. 2024;39(1):177. doi:10.1007/s10103-024-04115-x ↗
Kumar N, Kim HM, Nishikawa A, Heo CY, Wu WTL. Effectiveness of radiofrequency microneedling in the treatment of dermatological conditions: a systematic review. Aesthetic Plast Surg. 2026;50(13):5282–5317. doi:10.1007/s00266-026-05834-y ↗
Feldmeyer L, Bogdan I, Moser A, Specker R, Kamarashev J, French LE, Läuchli S. Short- and long-term efficacy and mechanism of action of tumescent suction curettage for axillary hyperhidrosis. J Eur Acad Dermatol Venereol. 2015;29(10):1933–1937. doi:10.1111/jdv.13078 ↗
Heidemann E, Licht PB. A comparative study of thoracoscopic sympathicotomy versus local surgical treatment for axillary hyperhidrosis. Ann Thorac Surg. 2013;95(1):264–268. doi:10.1016/j.athoracsur.2012.08.103 ↗
Lin ZY, Lin M. Which patients are more likely to experience compensatory hyperhidrosis after endoscopic thoracic sympathectomy: a meta-analysis and systematic review. PeerJ. 2025;13:e19097. doi:10.7717/peerj.19097 ↗

Centre for Surgery · CQC-regulated · GMC-registered surgeons · 95–97 Baker Street, Marylebone, London W1U 6RN · 020 7993 4849 · Book a consultation · Finance available, subject to status